Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Ravina, Megan Romer, R. Constantinescu, K. Biglan, A. Brocht, K. Kieburtz, I. Shoulson, M. Mcdermott (2008)The relationship between CAG repeat length and clinical progression in Huntington's disease
Movement Disorders, 23
R. Diego-Balaguer, C. Schramm, I. Rebeix, Emmanuel Dupoux, A. Durr, A. Brice, P. Charles, L. Langavant, K. Youssov, C. Verny, V. Damotte, J. Azulay, C. Goizet, C. Simonin, C. Tranchant, P. Maison, A. Rialland, David Schmitz, C. Jacquemot, B. Fontaine, A. Bachoud-Lévi (2016)COMT Val158Met Polymorphism Modulates Huntington's Disease Progression
PLoS ONE, 11
M. Raban, C. Bamford, Y. Joolay, M. Harrison (2015)Impact of an educational intervention and clinical performance dashboard on neonatal bloodstream infections.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 105 7
K. Kieburtz, J. Penney, P. Corno, N. Ranen, I. Shoulson, A. Feigin, D. Abwender, J. Greenarnyre, D. Higgins, F. Marshall, Joshua Goldstein, K. Steinberg, Charles Shih, I. Richard, C. Hickey, C. Zimmerman, C. Orme, Kathy Claude, D. Oakes, D. Sax, A. Kim, S. Hersch, Randi Jones, A. Auchus, D. Olsen, C. Bissey-Black, Allen Rubin, R. Schwartz, R. Dubinsky, William Mallonee, C. Gray, N. Godfrey, G. Suter, K. Shannon, G. Stebbins, J. Jaglin, K. Marder, Stuart Taylor, E. Louis, C. Moskowitz, Deborah Thorne, N. Zubin, N. Wexler, M. Swenson, Jane Paulsen, N. Swerdlow, R. Albin, Christine Wernette, F. Walker, V. Hunt (1996)Unified Huntington's disease rating scale: Reliability and consistency
Movement Disorders, 11
Jordan Swartz, J. Cimino, Matthew Fred, R. Green, D. Vawdrey (2014)Designing a Clinical Dashboard to Fill Information Gaps in the Emergency Department
AMIA ... Annual Symposium proceedings. AMIA Symposium, 2014
S. Tabrizi, D. Langbehn, B. Leavitt, R. Roos, A. Durr, D. Craufurd, C. Kennard, S. Hicks, Nick Fox, R. Scahill, B. Borowsky, A. Tobin, H. Rosas, H. Johnson, R. Reilmann, B. Landwehrmeyer, J. Stout (2009)Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
The Lancet Neurology, 8
E. Chandraharan, S. Arulkumaran (2016)The role of clinical dashboards in improving patient care: experience with the 'Maternity Dashboard'.
The Ceylon medical journal, 61 2
Jong-Min Lee, V. Wheeler, M. Chao, J. Vonsattel, R. Pinto, D. Lucente, K. Abu-Elneel, E. Ramos, J. Mysore, T. Gillis, M. MacDonald, J. Gusella, D. Harold, T. Stone, V. Escott-Price, Jun Han, Alexey Vedernikov, P. Holmans, L. Jones, S. Kwak, Mithra Mahmoudi, M. Orth, G. Landwehrmeyer, Jane Paulsen, E. Dorsey, I. Shoulson, R. Myers (2015)Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
J. Brandt, F. Bylsma, R. Gross, O. Stine, N. Ranen, C. Ross (1996)Trinucleotide repeat length and clinical progression in Huntington's disease
William Kuan, Andrea Kasis, Ye Yuan, S. Mason, Alpar Lazar, Roger Barker, Jorge Goncalves (2014)Modelling the natural history of Huntington's disease progression
Journal of Neurology, Neurosurgery & Psychiatry, 86
D. Mould, R. Upton, J. Wojciechowski (2014)Dashboard Systems: Implementing Pharmacometrics from Bench to Bedside
The AAPS Journal, 16
B. Felkey, B. Fox (2014)Health System Dashboard: It's All Coming Together
Hospital Pharmacy, 49
J. Phull, Julie Hall (2015)Clinical dashboards and their use in an adult mental health inpatient setting, a pilot study
Clinical Governance: An International Journal, 20
N. Mahant, E. McCusker, K. Byth, S. Graham (2003)Huntington’s disease
E. McCusker, F. Richards, D. Sillence, M. Wilson, R. Trent (2000)Huntington’s disease: neurological assessment of potential gene carriers presenting for predictive DNA testing
Journal of Clinical Neuroscience, 7
E. Beghi, Valentina Regio, A. Papantonio, A. Bentivoglio, A. Fasano, D. Fogli, L. Giordano, R. Piolti, G. Rinaldi, P. Simone, L. Specchio, P. Tonali, P. Torelli, M. Zarrelli, P. Messina (2014)Reliability of Clinical Diagnosis of Dystonia
B. Ghosh, R. Carpenter, J. Rowe (2013)A Longitudinal Study of Motor, Oculomotor and Cognitive Function in Progressive Supranuclear Palsy
PLoS ONE, 8
L. Beglinger, K. Duff, J. Allison, D. Theriault, J. O’Rourke, A. Leserman, Jane Paulsen (2010)Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status
Journal of Clinical and Experimental Neuropsychology, 32
J. Long, Jane Paulsen, K. Marder, Ying Zhang, Ji-in Kim, J. Mills (2014)Tracking motor impairments in the progression of Huntington's disease
Movement Disorders, 29
E. Dorsey, C. Beck, Kristin Darwin, P. Nichols, A. Brocht, K. Biglan, I. Shoulson (2013)Natural history of Huntington disease.
JAMA neurology, 70 12
Jeffrey Johnson (2010)Designing with the Mind in Mind: Simple Guide to Understanding User Interface Design Rules
A. Staib, Clair Sullivan, Matt Jones, Bronwyn Griffin, A. Bell, I. Scott (2017)The ED‐inpatient dashboard: Uniting emergency and inpatient clinicians to improve the efficiency and quality of care for patients requiring emergency admission to hospital
Emergency Medicine Australasia, 29
E. Chandraharan (2010)Clinical dashboards: do they actually work in practice? Three-year experience with the Maternity Dashboard
Clinical Risk, 16
G. El‐Nimr, S. Tams (2011)Working together: a one‐stop shop for Huntington's disease
Progress in Neurology and Psychiatry, 15
K. Kieburtz, M. MacDonald, Charles Shih, A. Feigin, K. Steinberg, Kathy Bordwell, C. Zimmerman, J. Srinidhi, J. Sotack, James Gusella, Ira Shoulson (1994)Trinucleotide repeat length and progression of illness in Huntington's disease.
Journal of Medical Genetics, 31
R. Myers, D. Sax, W. Koroshetz, C. Mastromauro, L. Cupples, D. Kiely, Pettengill Fk, E. Bird (1991)Factors associated with slow progression in Huntington's disease.
Archives of neurology, 48 8
S. Kirkwood, J. Su, P. Conneally, T. Foroud (2001)Progression of symptoms in the early and middle stages of Huntington disease.
Archives of neurology, 58 2
Michal Novotný, J. Rusz, R. Cmejla, Hana Ruzickova, J. Klempír, E. Růžička (2016)Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease
A. Rosenblatt, K. Liang, H. Zhou, M. Abbott, L. Gourley, R. Margolis, Jason Brandt, Christopher Ross (2006)The association of CAG repeat length with clinical progression in Huntington disease
Jurgen Lemiere, M. Decruyenaere, Gery Evers-Kiebooms, Erik Vandenbussche, René Dom (2004)Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation
Journal of Neurology, 251
S. Andrew, Y. Goldberg, B. Kremer, H. Telenius, J. Theilmann, S. Adam, E. Starr, F. Squitieri, B. Lin, M. Kalchman, R. Graham, M. Hayden (1993)The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
Nature Genetics, 4
J. Tedroff, S. Waters, R. Barker, R. Roos, F. Squitieri (2015)Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease.
Journal of Huntington's disease, 4 2
Background: In Huntington’s disease (HD), it remains unclear how symptom severity and rate of symptomatic change relates to age and CAG repeat number (CAGn). It is often difficult for clinicians to assess whether an affected individual’s symptoms are progressing at a similar rate to their affected peers, limiting their ability to intervene at the most appropriate time.Objective: To develop a clinical dashboard that compares an individual’s total motor score (TMS), total functional capacity (TFC) and symbol digit modality test (SDMT) scores against a global cohort, controlling for age and CAGn. The dashboard could then be used by clinicians to identify individuals progressing at a disproportionate rate to his or her peers.Methods: Annualised longitudinal clinical assessment scores from the Enroll-HD dataset were used to generate decline trajectories of the global cohort, allowing cross-sectional (TMS n = 734; TFC n = 734; SDMT n = 694) and longitudinal (TMS n = 270; TFC n = 270; SDMT n = 247) comparison with individual clinical symptom rating scores, to assess decline relative to affected peers.Results: An electronic dashboard with a dynamic output display was created that rapidly compares clinical symptom rating scores of a specific individual against affected peers from a global cohort of comparable CAGn.Conclusions: This study shows the potential for use of multi-centre trial data in allowing comparison of the individual to a larger group to facilitate improved decision-making for individual patients. Visualisation of these metrics via a clinical dashboard demonstrates how it may aid identification of those with disproportionate decline, offering potential for intervention at specific critical points in the disease course.
Journal of Huntington's Disease – IOS Press
Published: Jan 1, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.